Progressive recruitment of Runx2 to genomic targets despite decreasing expression during osteoblast differentiation
- 26 September 2008
- journal article
- fast track
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 105 (4) , 965-970
Abstract
The mRNAs encoding Runx2, a master osteoblast transcription factor, and its target gene Osteocalcin (OC), are commonly used as markers of osteoblast differentiation. We found that while OC mRNA levels do indeed increase during development of the osteoblast phenotype in MC3T3‐E1 cultures, Runx2 mRNA levels surprisingly decrease. Neither translational control of Runx2 (based on Western analysis) nor regulation of its DNA‐binding ability (assessed by electrophoretic mobility shift assay) could explain the unexpected opposite patterns of Runx2 and OC expression. Instead, a series of chromatin immunoprecipitation (ChIP) assays during osteoblast differentiation revealed that early on, when Runx2 protein amount and DNA‐binding activity are maximal, it is practically absent from the OC promoter. At later stages, Runx2 is recruited to the OC promoter while Runx2 mRNA, protein, and in vitro DNA binding progressively decrease. We also followed Runx2 occupancy at a novel genomic target discovered by ChIP‐Chip analysis of cells in which the OC promoter is maximally occupied. The results revealed that Runx2 is recruited to this locus and to the OC promoter with a remarkably similar temporal pattern. These observations highlight a mechanism that restrains Runx2‐mediated transcriptional control by confining its access to genomic targets to a narrow window of time. The need for such stringent control is consistent with the severe consequences of Runx2 over‐expression in vivo. J. Cell. Biochem. 105: 965–970, 2008.Keywords
This publication has 34 references indexed in Scilit:
- Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional CapacityPLOS ONE, 2008
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- Identification of novel Runx2 targets in osteoblasts: Cell type‐specific BMP‐dependent regulation of Tram2Journal of Cellular Biochemistry, 2007
- Brief Bone Morphogenetic Protein 2 Treatment of Glucocorticoid-inhibited MC3T3-E1 Osteoblasts Rescues Commitment-associated Cell Cycle and Mineralization without Alteration of Runx2Journal of Biological Chemistry, 2003
- Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiationGenes & Development, 2003
- Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathwaysJournal of Cellular Biochemistry, 2003
- Translational Regulation Is a Control Point in RUNX2/Cbfa1 Gene ExpressionBiochemical and Biophysical Research Communications, 2001
- Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell CycleJournal of Biological Chemistry, 2000
- Increased bone formation in osteocalcin-deficient miceNature, 1996
- Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domainEndocrinology, 1996